Molly Stevens Ph.D.

Stevens, Molly
Position Department / Business Unit
Reader in Regenerative Medicine and Nanotechnology Materials Science and Engineering
Institution Disciplines
Imperial College London Nanomedicine Engineering
City State / Provence
London England
Country Website
United Kingdom link

Molly Stevens is currently Reader in Regenerative Medicine and Nanotechnology.

She joined Imperial in 2004 after spending several years as a Postdoctoral Associate working in the field of tissue engineering with Professor Robert Langer in the Chemical Engineering Department at the Massachusetts Institute of Technology (MIT).  In 2005 she was awarded the prestigious Philip Leverhulme Prize. She has also recently been recognised by the TR100, a compilation of the top innovators, under the age of 35, who are transforming technology - and the world with their work. Her previous awards include the Ronald Belcher Memorial Lecture Award from the Royal Society of Chemistry (2000) and both the Janssen Prize and the UpJohn Prize for academic excellence and research. 

Her group is extremely multidisciplinary and currently consists of 11 students and 6 postdocs/fellows. Research in regenerative medicine within her group includes the directed differentiation of stem cells, the design of novel bioactive scaffolds and new approaches towards tissue regeneration. She has developed novel approaches to tissue engineering that are likely to prove very powerful in the engineering of large quantities of human mature bone for autologous transplantation as well as other vital organs such as liver and pancreas, which have proven elusive with other approaches. This has led to moves to commercialise the technology and set-up a clinical trial for bone regeneration in humans. In the field of nanotechnology the group has current research efforts in exploiting specific biomolecular recognition and self-assembly mechanisms to create new dynamic nano-materials, biosensors and drug delivery systems.


Dr. Stevens graduated from Bath University with a first class honours degree in Pharmaceutical Sciences. She earned her PhD in biophysical investigations of specific biomolecular interactions from the University of Nottingham (2000).

By this Researcher

Related Content